Capital Offload-Shock

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 456 participants.

Also called NCT07756801

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 456 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07756801
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Canada (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07756801. Randomized; no masking; primary purpose treatment. Start 2026-12-01 (anticipated); primary completion 2027-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Capital Offload-Shock
Acronym
OFFLOAD-SHOCK
Condition
Hypervolemia
Condition
Cardiogenic Shock
Condition
Renal Replacement Therapies
Intervention (Drug)
Immediate renal replacement therapy
Lead sponsor
Ottawa Heart Institute Research Corporation (class: other)

Record details

Record id
cardio:ct-nct07756801
Content hash
ff85e4dcbf7f2dc8dd837e387be96fe1f3e77c69dfdeb8f050ede663cb15e3d1